Keren Farin
Overview
Explore the profile of Keren Farin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farin K, Schokoroy S, Haklai R, Cohen-Or I, Elad-Sfadia G, Reyes-Reyes M, et al.
Cancer Res
. 2011 Jan;
71(6):2140-51.
PMID: 21257709
Alterations in the ErbB family of growth factor receptors, their signaling components, and mutational activation of Ras proteins are major contributors to malignant transformation. Recently, mutant Ras was shown to...
2.
Farin K, Segni A, Mor A, Pinkas-Kramarski R
PLoS One
. 2009 Jul;
4(7):e6128.
PMID: 19578540
Background: The ErbB receptor tyrosine kinases and nucleolin are major contributors to malignant transformation. Recently we have found that cell-surface ErbB receptors interact with nucleolin via their cytoplasmic tail. Overexpression...
3.
Segni A, Farin K, Pinkas-Kramarski R
PLoS One
. 2008 Jun;
3(6):e2310.
PMID: 18523588
Background: The ErbB receptor tyrosine kinases are major contributors to malignant transformation. These receptors are frequently overexpressed in a variety of human carcinomas. The role of the ErbB receptors and...
4.
Segni A, Farin K, Pinkas-Kramarski R
J Mol Neurosci
. 2006 Nov;
29(3):257-67.
PMID: 17085783
The neuroprotective effects of neuregulin (NRG), a polypeptide growth factor, on 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell death and oxidative stress in PC12-ErbB4 cells were investigated. Treatment of PC12-ErbB4 cells with MPP+...